And from the wide world of Carlsbad businesses that we don’t understand or know anything about comes this stunner:
Invitrogen Corporation and Clontech Laboratories, Inc. have jointly announced a confidential settlement of their patent litigation, following a jury decision last week in federal district court in Greenbelt, Maryland. As part of the settlement, Clontech has agreed that Invitrogen Patent Nos. 5,244,797, 5,668,005, 6,063,608, and 5,405,776 on RNase H minus reverse transcriptase (RT) are valid and enforceable. Clontech has discontinued sales of its RNase H minus RT products, including its PowerScript products, for the life of the patents. The parties did not disclose other details of their agreement.
We’re sure there are quite a few Invitrogen employee who will be sleeping better tonight, in their Carlsbad beds.
[Link: Business Wire]
RSS Feed-Posts
{ 0 comments… add one now }